Potential and limitations of genetic manipulation in animals

Drug Discovery Today: Technologies

Volumn 3, Issue 2, 2006, Pages 173-180

  O'Sullivan, Gerard J ^a   O'Tuathaigh, Colm M ^a   Clifford, Jeremiah J ^a   O'Meara, Gillian F ^a   Croke, David T ^a   Waddington, John L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ETHYLNITROSOUREA; RNA; SMALL INTERFERING RNA;

DNA VIRUS; DRUG MECHANISM; FUNCTIONAL GENOMICS; GENE SEQUENCE; GENE TARGETING; GENETIC ENGINEERING; GENETIC MANIPULATION; GENOME ANALYSIS; HOMOLOGOUS RECOMBINATION; KNOCKOUT MOUSE; MUTAGENESIS; NONHUMAN; PLEIOTROPY; REVIEW; RNA INTERFERENCE; TRANSGENIC ANIMAL; TRANSGENICS; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

EID: 33746192057     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2006.06.005     Document Type: Review

References (49)

1. Costantini F., and Lacy E. Introduction of a rabbit beta-globin gene into the mouse germ line. Nature 294 (1981) 92-94
2. Gordon J.W., and Ruddle F.H. Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 214 (1981) 1244-1246
3. Harbers K., et al. Microinjection of cloned retroviral genomes into mouse zygotes: integration and expression in the animal. Nature 293 (1981) 540-542
4. Wagner E.F., et al. The human beta-globin gene and a functional viral thymidine kinase gene in developing mice. Proc. Natl. Acad. Sci. U S A 78 (1981) 5016-5020
5. Lee D., and Threadgill D.W. Investigating gene function using mouse models. Curr. Opin. Genet. Dev. 14 (2004) 246-252
6. Bockamp E., et al. Of mice and models: improved animal models for biomedical research. Physiol. Genomics 11 (2002) 115-132
7. Waddington J.L., et al. The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout'). Prog. Neuropsychopharmacol. Biol. Psychiatry 25 (2001) 925-964
8. Waddington J.L., et al. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. Psychopharmacology 181 (2005) 611-638
9. Barthold S.W. Genetically altered mice: phenotypes, no phenotypes, and faux phenotypes. Genetica 122 (2004) 75-88
10. Crusio W.E. Flanking gene and genetic background problems in genetically manipulated mice. Biol. Psychiatry 56 (2004) 381-385
11. Gingrich J.A., and Hen R. The broken mouse: the role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice. Curr. Opin. Neurobiol. 10 (2000) 146-152
12. Nadeau J.H. Modifier genes and protective alleles in humans and mice. Curr. Opin. Genet. Dev. 13 (2003) 290-295
13. Lewandoski M. Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2 (2001) 743-755
14. Kwan K.M. Conditional alleles in mice: practical considerations for tissue-specific knockouts. Genesis 32 (2002) 49-62
15. Morozov A., et al. Using conditional mutagenesis to study the brain. Biol. Psychiatry 54 (2003) 1125-1133
16. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U S A 89 (1992) 5547-5551
17. Glaser S., et al. Current issues in mouse genome engineering. Nat. Genet. 37 (2005) 1187-1193
18. Szulc J., et al. A versatile tool for conditional gene expression and knockdown. Nat. Methods 3 (2006) 109-116
19. Cecconi F., and Meyer B.I. Gene trap: a way to identify novel genes and unravel their biological function. FEBS Lett. 480 (2000) 63-71
20. Waterston R.H., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420 (2002) 520-562
21. Austin C.P., et al. The knockout mouse project. Nat. Genet. 36 (2004) 921-924
22. Auwerx J., et al. The European dimension for the mouse genome mutagenesis program. Nat. Genet. 36 (2004) 925-927
23. Stanford W.L., et al. Gene-trap mutagenesis: past, present and beyond. Nat. Rev. Genet. 2 (2001) 756-768
24. Skarnes W.C., et al. A public gene trap resource for mouse functional genomics. Nat. Genet. 36 (2004) 543-544
25. Guenet J.L. Chemical mutagenesis of the mouse genome: an overview. Genetica 122 (2004) 9-24
26. Cordes S.P. N-ethyl-N-nitrosourea mutagenesis: boarding the mouse mutant express. Microbiol. Mol. Biol. Rev. 69 (2005) 426-439
27. Rathkolb B., et al. Large-scale N-ethyl-N-nitrosourea mutagenesis of mice-from phenotypes to genes. Exp. Physiol. 85 (2000) 635-644
28. Beier D.R., and Herron B.J. Genetic mapping and ENU mutagenesis. Genetica 122 (2004) 65-69
29. O'Brien T.P., and Frankel W.N. Moving forward with chemical mutagenesis in the mouse. J. Physiol. 554 (2004) 13-21
30. Yu Y., and Bradley A. Engineering chromosomal rearrangements in mice. Nat. Rev. Genet. 2 (2001) 780-790
31. Forster A., et al. Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. Cancer Cell 3 (2003) 449-458
32. Copeland N.G., et al. Recombineering: a powerful new tool for mouse functional genomics. Nat. Rev. Genet. 2 (2001) 769-779
33. Izsvak Z., and Ivics Z. Sleeping Beauty hits them all: transposon-mediated saturation mutagenesis in the mouse germline. Nat. Methods 2 (2005) 735-736
34. Keng V.W., et al. Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. Nat. Methods 2 (2005) 763-769
35. Peng Z. Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum. Gene Ther. 16 (2005) 1016-1027
36. Young L.S., et al. Viral gene therapy strategies: from basic science to clinical application. J. Pathol. 208 (2006) 299-318
37. Pfeifer A. Lentiviral transgenesis. Transgenic Res. 13 (2004) 513-522
38. Mittal V. Improving the efficiency of RNA interference in mammals. Nat. Rev. Genet. 5 (2004) 355-365
39. Dorsett Y., and Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3 (2004) 318-329
40. Zimmermann T.S., et al. RNAi-mediated gene silencing in non-human primates. Nature 441 (2006) 111-114
41. Tesson L., et al. Transgenic modifications of the rat genome. Transgenic Res. 14 (2005) 531-546
42. Gibbs R.A., et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428 (2004) 493-521
43. Zan Y., et al. Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat. Biotechnol. 21 (2003) 645-651
44. Smits B.M., et al. Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis. Pharmacogenet. Genomics 16 (2006) 159-169
45. Williams R.W., et al. The math of making mutant mice. Genes Brain Behav. 2 (2003) 191-200
46. Bogue M.A., and Grubb S.C. The Mouse Phenome Project. Genetica 122 (2004) 71-74
47. Bilen J., and Bonini N.M. Drosophila as a model for human neurodegenerative disease. Annu. Rev. Genet. 39 (2005) 153-171
48. Kaletta T., and Hengartner M.O. Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 5 (2006) 387-399
49. Zon L.I., and Peterson R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 4 (2005) 35-44